New York U.S. Senator Kirsten Gillibrand toured the Trudeau Institute in Saranac Lake earlier this week. The research center is famed for its study of lung diseases, but a new arm of the institute will be dedicated to immuno-engineering studies of Lyme disease.
Memorandum of Understanding signed between Clarkson University President Tony Collins (left), Empire State Development President, CEO and Commissioner Kenneth Adams (center), and Trudeau Institute President, Director and CEO Ronald H. Goldfarb (right)
The Trudeau Institute in Saranac Lake recently named a new leader for the scientific research facility.
The board of trustees of the biomedical research institute in the Adirondacks named Dr. Ronald H. Goldfarb to lead the Trudeau Institute beginning on October first. Goldfarb has more than 30 years academic and industrial experience in cancer research, and co-founded a biopharmaceutical company. He has been on numerous peer-review panels and scientific advisory boards, and edited cancer journals. He is the Trudeau Institute’s sixth President, Director and CEO.